COMMUNIQUÉS West-GlobeNewswire

Eve & Co Announces Appointment of Ivan Ross Vrána as VP Government Relations and Business Development
31/05/2019
TORONTO, May 31, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce that Ivan Ross Vrána has been appointed as a Vice President and will [...]
Envarsus XR® to be Subject of Upcoming Presentations at 2019 American Transplant Congress
31/05/2019
Investor News no. 03/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 May 2019 Envarsus XR® to be Subject of Upcoming Presentations at 2019 American Transplant Congress Veloxis Pharmaceuticals (OMX: VELO) [...]
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31/05/2019
CAMBRIDGE, Mass., May 31, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]
Novan Announces 2019 Annual Meeting of Stockholders for July 31, 2019
31/05/2019
MORRISVILLE, N.C., May 31, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN) today announced that it will hold its 2019 Annual Meeting of Stockholders on Wednesday, July 31, at 9:30 am [...]
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31/05/2019
HOUSTON, May 31, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Digirad Corporation Announces Reverse Stock Split
31/05/2019
1-for-10 Reverse Stock Split Effective June 4, 2019 for Trading June 5, 2019 SUWANEE, Ga., May 31, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) (“Digirad” or “the Company”) today announced a reverse stock [...]
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 21, 2019
31/05/2019
LYON, France, May 31, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red [...]
ERYTECH annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 21 juin 2019
31/05/2019
LYON, France, 31 mai 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris : ERYP – Nasdaq : ERYP), société biopharmaceutique en phase clinique développant des thérapies innovantes par encapsulation de substances [...]
Tecan successfully completes the acquisition of supplier of key parts
31/05/2019
Männedorf, Switzerland, May 31, 2019 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of a supplier of key parts. On March 22, 2019, Tecan announced the [...]
Rafarma: Now “Growing” More Than Ever!
31/05/2019
Ljubljana, Slovenia, May 31, 2019 (GLOBE NEWSWIRE) -- RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)”, a Wyoming Corporation, is pleased to announce approval of its application for farming cannabis in Slovenia through its [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
31/05/2019
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 31 mai 2019 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Draft resolutions of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on June 17th, 2019
31/05/2019
Draft resolutions of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on June 17th, 2019 : 1. Report of the Board on results of operations in 2018. Draft resolution: To take notice of the Report [...]
Constellation Pharmaceuticals to Present at Jefferies Healthcare Conference
31/05/2019
CAMBRIDGE, Mass., May 31, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]
Syneos Health Appoints Patrick Nealon, Head of Oncology
31/05/2019
MORRISVILLE, N.C., May 31, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Patrick Nealon as Executive Vice [...]
Major shareholder announcement
31/05/2019
Orphazyme A/S Company announcement No. 14/2019 Company Registration No. 32266355 Copenhagen, May 31, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients [...]
2019 American Society of Clinical Oncology (ASCO) Annual Meeting - Darolutamide data presented
31/05/2019
Orion Corporation Press release 31 May 2019 at 5.00 p.m. EEST 2019 American Society of Clinical Oncology (ASCO) Annual Meeting - Darolutamide data presented Orion's and Bayer's darolutamide plus androgen deprivation [...]
Hemispherx Biopharma Stockholders Approve Reverse Stock Split
31/05/2019
OCALA, Fla., May 31, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and [...]
Result of Annual General Meeting
31/05/2019
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announces that at the Annual General Meeting held [...]
Olainfarm Group’s revenue in the first quarter reaches 34.7 million EUR; net profit tops 8.3 million EUR
31/05/2019
During the 1st quarter of 2019, consolidated sales of the Olainfarm Group reached 34.7 million euros which is an increase by 4 million euros or 13% if compared to similar period of 2018. Such result marks a new record [...]

Pages